Tadalafil for the treatment of symptoms associated with benign prostatic hyperplasia (terminated appraisal)

Hyperplasia (benign prostatic) - tadalafil: equality impact assessment - scoping

Hyperplasia (benign prostatic) - tadalafil: response to consultee and commentator comments on the draft scope and provisional matrix

Hyperplasia (benign prostatic) - tadalafil: final matrix

Hyperplasia (benign prostatic) - tadalafil: final scope

Hyperplasia (benign prostatic) - tadalafil: Appendix B - draft scope for consultation (pre-referral) - January 2012 

Hyperplasia (benign prostatic) - tadalafil: Appendix C - provisional matrix (pre-referral) - January 2012